0001209191-12-021645.txt : 20120403 0001209191-12-021645.hdr.sgml : 20120403 20120403203811 ACCESSION NUMBER: 0001209191-12-021645 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120330 FILED AS OF DATE: 20120403 DATE AS OF CHANGE: 20120403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LUNDBERG MAGNUS CENTRAL INDEX KEY: 0001235944 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 12739981 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-0000 MAIL ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0305 4 2012-03-30 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001235944 LUNDBERG MAGNUS C/O ONYX PHARMACEUTICALS, INC. 249 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2012-03-30 4 A 0 3000 0.00 A 10616 D Stock Option (Right to Buy) 37.68 2012-03-30 4 A 0 5000 0.00 A 2013-03-30 2022-03-30 Common Stock 5000 5000 D Represents a restricted stock award granted to the reporting person. The award vests on the first anniversary of the grant date. Magnus Lundberg, by /s/ Warren De Souza, Attorney-in-Fact 2012-04-03